IMUX
Price
$0.92
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
88.22M
76 days until earnings call
IOBT
Price
$1.20
Change
+$0.09 (+8.11%)
Updated
May 22 closing price
Capitalization
79.06M
77 days until earnings call
Interact to see
Advertisement

IMUX vs IOBT

Header iconIMUX vs IOBT Comparison
Open Charts IMUX vs IOBTBanner chart's image
Immunic
Price$0.92
Change-$0.00 (-0.00%)
Volume$204.39K
Capitalization88.22M
IO Biotech
Price$1.20
Change+$0.09 (+8.11%)
Volume$412.53K
Capitalization79.06M
IMUX vs IOBT Comparison Chart
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. IOBT commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and IOBT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (IMUX: $0.92 vs. IOBT: $1.20)
Brand notoriety: IMUX and IOBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 22% vs. IOBT: 240%
Market capitalization -- IMUX: $88.22M vs. IOBT: $79.06M
IMUX [@Biotechnology] is valued at $88.22M. IOBT’s [@Biotechnology] market capitalization is $79.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileIOBT’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • IOBT’s FA Score: 0 green, 5 red.
According to our system of comparison, IOBT is a better buy in the long-term than IMUX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 3 TA indicator(s) are bullish while IOBT’s TA Score has 6 bullish TA indicator(s).

  • IMUX’s TA Score: 3 bullish, 7 bearish.
  • IOBT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IOBT is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -7.53% price change this week, while IOBT (@Biotechnology) price change was +17.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

IMUX is expected to report earnings on Aug 07, 2025.

IOBT is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMUX($88.2M) has a higher market cap than IOBT($79.1M). IOBT YTD gains are higher at: 30.435 vs. IMUX (-7.930). IOBT has higher annual earnings (EBITDA): -89.37M vs. IMUX (-95.68M). IOBT has more cash in the bank: 80.2M vs. IMUX (59.1M). IMUX has less debt than IOBT: IMUX (899K) vs IOBT (2.02M). IMUX (0) and IOBT (0) have equivalent revenues.
IMUXIOBTIMUX / IOBT
Capitalization88.2M79.1M112%
EBITDA-95.68M-89.37M107%
Gain YTD-7.93030.435-26%
P/E RatioN/AN/A-
Revenue00-
Total Cash59.1M80.2M74%
Total Debt899K2.02M45%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXIOBT
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 25 days ago
87%
Bullish Trend 1 day ago
90%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRO0.900.06
+7.67%
Sutro Biopharma
EVTL5.440.27
+5.22%
Vertical Aerospace Ltd
XOM103.66N/A
N/A
Exxon Mobil Corp
MYGN4.07N/A
N/A
Myriad Genetics
SF94.30-0.20
-0.21%
Stifel Financial Corp

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with GLMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
+8.11%
GLMD - IOBT
35%
Loosely correlated
N/A
DYN - IOBT
34%
Loosely correlated
N/A
RCKT - IOBT
33%
Poorly correlated
N/A
RGNX - IOBT
29%
Poorly correlated
N/A
QSI - IOBT
28%
Poorly correlated
+17.97%
More